Does fatty liver disease cause jaundice? This is a common concern for people diagnosed with hepatic steatosis or those worried about their liver health. Simple fatty liver disease does not typically cause jaundice in its early or intermediate stages. Jaundice—characterised by yellowing of the skin and eyes—only develops when fatty liver has progressed to advanced cirrhosis or acute liver failure, conditions that severely impair the liver's ability to process bilirubin. The vast majority of people with fatty liver disease will never develop jaundice, particularly with appropriate lifestyle modifications and medical management to prevent disease progression.

Understanding Fatty Liver Disease and Its Symptoms

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates within liver cells. This condition exists in two main forms: non-alcoholic fatty liver disease (NAFLD) (also increasingly referred to as metabolic dysfunction-associated steatotic liver disease, or MASLD), which develops in people who drink little or no alcohol, and alcohol-related liver disease (ARLD), caused by excessive alcohol consumption. NAFLD has become increasingly common in the UK, affecting approximately one in three adults, often associated with obesity, type 2 diabetes, and metabolic syndrome.

In its early stages, fatty liver disease typically produces no noticeable symptoms. Most people remain unaware they have the condition until it is detected incidentally during blood tests or imaging scans performed for other reasons. When symptoms do occur, they tend to be vague and non-specific, including persistent fatigue, general malaise, or a dull ache in the upper right abdomen where the liver is located.

The condition exists on a spectrum of severity. Simple fatty liver (steatosis) is generally benign and may remain stable for years in many individuals. However, in some people, it can progress to non-alcoholic steatohepatitis (NASH) or alcohol-related hepatitis, where inflammation damages liver cells. Over time, repeated inflammation and repair can lead to fibrosis (scarring). Advanced scarring results in cirrhosis, where the liver's architecture becomes severely distorted and its function significantly impaired.

Risk factors for developing fatty liver disease include obesity (particularly central adiposity), insulin resistance, high cholesterol or triglycerides, hypertension, and metabolic syndrome. Certain medications, rapid weight loss, and some genetic conditions can also contribute. Understanding these risk factors helps identify individuals who may benefit from assessment and lifestyle interventions to prevent disease progression. UK guidance does not recommend routine population screening for NAFLD, but supports targeted case-finding and risk stratification in people with metabolic risk factors or persistently abnormal liver blood tests.

Does Fatty Liver Disease Cause Jaundice?

Simple fatty liver disease does not typically cause jaundice. In the early and intermediate stages of NAFLD or ARLD, liver function generally remains adequate, and bilirubin metabolism—the process responsible for preventing jaundice—continues normally. Jaundice, characterised by yellowing of the skin and whites of the eyes, occurs when bilirubin (a yellow pigment produced from the breakdown of red blood cells) accumulates in the bloodstream because the liver cannot process it effectively.

Jaundice becomes a potential complication only when fatty liver disease has progressed to advanced stages, particularly cirrhosis or acute liver failure. In cirrhosis, extensive scarring severely impairs the liver's ability to conjugate and excrete bilirubin. When cirrhosis decompensates—meaning the liver can no longer maintain its essential functions—jaundice may develop alongside other serious complications such as ascites (fluid accumulation in the abdomen), hepatic encephalopathy (confusion due to toxin build-up), and variceal bleeding.

Acute alcohol-related hepatitis, a severe inflammatory condition that can occur in people with alcohol-related liver disease, may also present with jaundice. This represents a medical emergency requiring urgent assessment. The presence of jaundice in someone with known or suspected fatty liver disease suggests significant hepatocellular dysfunction and warrants immediate medical evaluation.

It is important to note that whilst there is a pathway from fatty liver to jaundice through disease progression, the vast majority of people with fatty liver disease will never develop jaundice. With appropriate lifestyle modifications—including weight loss (aiming for 7–10% body weight reduction), dietary changes, increased physical activity, and alcohol cessation where relevant—many individuals can prevent progression to advanced liver disease. Regular assessment through blood tests (liver function tests) and, when indicated, non-invasive fibrosis risk stratification (using scores such as FIB-4 or the NAFLD Fibrosis Score, followed by the Enhanced Liver Fibrosis [ELF] test or transient elastography [FibroScan] if needed) helps identify those at higher risk of progression who may benefit from specialist hepatology referral and more intensive management.

Other Causes of Jaundice to Consider

Jaundice has numerous potential causes beyond advanced liver disease, and identifying the underlying aetiology is essential for appropriate management. Causes can be broadly categorised into pre-hepatic (before the liver), hepatic (within the liver), and post-hepatic (after the liver, involving bile ducts).

Pre-hepatic causes involve excessive breakdown of red blood cells (haemolysis), overwhelming the liver's capacity to process bilirubin. Conditions include haemolytic anaemias, such as sickle cell disease, hereditary spherocytosis, or glucose-6-phosphate dehydrogenase (G6PD) deficiency. Gilbert's syndrome, a common benign genetic condition affecting approximately 5% of the population, causes mild intermittent jaundice due to reduced bilirubin conjugation, often noticed during illness or fasting.

Hepatic causes involve direct liver cell damage or dysfunction. Viral hepatitis (hepatitis A, B, C, or E) remains a common cause globally. Autoimmune hepatitis, where the immune system attacks liver cells, can present with jaundice. Drug-induced liver injury from medications such as paracetamol overdose (a medical emergency requiring immediate A&E attendance), certain antibiotics (co-amoxiclav, flucloxacillin), or herbal supplements can cause acute hepatitis. If you suspect a medicine has caused jaundice or abnormal liver tests, report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. Primary biliary cholangitis and primary sclerosing cholangitis are chronic conditions affecting bile ducts within the liver.

Post-hepatic (obstructive) causes prevent bile from flowing from the liver to the intestine. Gallstones blocking the common bile duct are common, particularly in older adults. Pancreatic cancer or cholangiocarcinoma (bile duct cancer) can obstruct bile flow and typically present with painless jaundice, often accompanied by weight loss and pale stools. Adults with obstructive or painless jaundice should receive an urgent suspected cancer referral (2-week wait pathway) in line with NICE guidance. Strictures from previous surgery or inflammation may also cause obstruction.

Investigation typically includes liver function tests (measuring bilirubin, alanine aminotransferase [ALT], aspartate aminotransferase [AST], gamma-glutamyl transferase [GGT], alkaline phosphatase [ALP], and albumin), full blood count, clotting studies (including INR/prothrombin time), and ultrasound imaging to assess liver structure and bile ducts. Further tests such as viral hepatitis serology, autoimmune markers, or advanced imaging (CT, MRCP) may be required depending on initial findings.

When to Seek Medical Advice for Liver Symptoms

Jaundice always requires prompt medical assessment. If you notice yellowing of your skin or the whites of your eyes, contact your GP immediately or, if accompanied by severe symptoms, attend the emergency department. Jaundice indicates significant disruption to normal liver or bile duct function and requires investigation to determine the underlying cause and appropriate treatment.

Seek urgent medical attention (call 999 or attend A&E) if jaundice is accompanied by:

• Severe abdominal pain, particularly in the upper right quadrant, especially with high fever and rigors (shaking chills), which may indicate cholangitis (infected bile ducts)

• Confusion, drowsiness, or altered behaviour, suggesting hepatic encephalopathy

• Vomiting blood or passing black, tarry stools, indicating gastrointestinal bleeding

• Signs of severe systemic illness, such as rapid breathing, low blood pressure, or reduced consciousness

Contact your GP urgently the same day or call NHS 111 if jaundice occurs with:

• Severe itching (pruritus) that is intolerable

• Easy bruising or prolonged bleeding without active haemorrhage

• Persistent vomiting or inability to keep fluids down

If you have taken a paracetamol overdose or suspect paracetamol poisoning, attend A&E immediately, even if you feel well, as liver damage may develop over hours to days.

For those with known fatty liver disease, regular assessment is important even without symptoms. Contact your GP if you experience:

• Persistent fatigue that interferes with daily activities

• Unexplained weight loss

• New or worsening abdominal discomfort or swelling

• Ankle swelling (oedema) or abdominal distension

• Loss of appetite or feeling full quickly after eating

NICE guidance (NG49) recommends that adults with NAFLD should be reassessed for advanced fibrosis every three years using non-invasive tests such as the FIB-4 score or NAFLD Fibrosis Score. If these scores are indeterminate or suggest higher risk, second-line tests such as the Enhanced Liver Fibrosis (ELF) blood test or transient elastography (FibroScan) may be used. Those with advanced fibrosis or cirrhosis require specialist hepatology follow-up, including surveillance for hepatocellular carcinoma (HCC) with ultrasound scans every six months and assessment for oesophageal varices.

Prevention and early intervention remain key. If you have risk factors for fatty liver disease—obesity, diabetes, high cholesterol, or excessive alcohol consumption—discuss assessment and risk stratification with your GP. Lifestyle modifications, including achieving a healthy weight through diet and exercise (aiming for 7–10% weight loss if overweight), moderating or stopping alcohol intake, and optimising management of metabolic conditions, can significantly reduce the risk of progression to advanced liver disease and its complications, including jaundice.

Frequently Asked Questions